Axial Therapeutics announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private...
Read moreAxial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinson’s Research to support its efforts...
Read moreKairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...
Read moreWe're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...
Read moreThis month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...
Read moreAxial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...
Read more